Hundred-Million-Dollar Mud
In March 2026, the corporate world watched as Finch Therapeutics, a company that once promised to turn human waste into a billion-dollar FDA-approved drug, spectacularly imploded. This episode takes you deep into the forensic audit of Finch's downfall, a chilling narrative of ambition, regulation, and biological entropy. Our hosts, the cynical, street-level Marcus and the clinically detached Katie, dissect the "Ostrich Algorithm" that led to Finch burying its head in data while its pipes burst. From the initial public offering of $960 million to a fire sale at $16.9 million, they explore how…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.